Biotechnology - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

26 to 50 of 174 results

Stem cell rules clear and adequate, says Philippines FDA

Stem cell rules clear and adequate, says Philippines FDA

14-10-2013

The Philippines Food and Drug Administration (PFDA) has said its guidelines governing stem cell therapy…

Asia-PacificBiotechnologyRegulation

CuroNZ gets funding for potential MS treatment

14-10-2013

CuroNZ has been awarded funding of US$540,000 from New Zealand's National Multiple Sclerosis Society…

Asia-PacificBiotechnologyCuroNZFinancialResearch

AusBiotech 2013 annual report shows year of solid delivery

10-10-2013

The AusBiotech Annual Report 2013 has now been released, detailing another solid performance for AusBiotech…

Asia-PacificBiotechnologyFinancialPoliticsResearch

Immutep and Eddingpharm sign accord for ImmuFact IMP321 in China

07-10-2013

French biopharma Immutep and Chinese drugmaker Eddingpharm have entered into an agreement for the development,…

Asia-PacificBiotechnologyLicensingMarkets & MarketingOncologyResearch

Amgen to open China R&D Center at ShanghaiTech

28-09-2013

Amgen and ShanghaiTech University have entered into a memorandum of understanding to form a strategic…

AmgenAsia-PacificBiotechnologyResearch

AusBiotech joins forces with Cook Medical and Deloitte on tax

27-09-2013

Australian biotechnology industry experts are joining forces to support a “patent box” tax incentive,…

Asia-PacificBiotechnologyFinancialPatentsResearch

Easier access to funded enzyme replacement therapy proposed in New Zealand

20-09-2013

New Zealand’s Pharmaceutical Management Agency PHARMAC is providing greater funded access to the expensive…

Asia-PacificBiotechnologyFinancialGenzymeRare diseasesRelvar ElliptaSanofi

AusBiotech welcomes new venture capital fund for biotech

22-08-2013

Trade group AusBiotech has commended the Australian Labor government's response to the Strategic Review…

Asia-PacificBiotechnologyFinancialPoliticsResearch

Sirona Biochem signs LoI with leading Chinese diabetes company

22-08-2013

Canada's Sirona Biotech (TSX VENTURE:SBM) has signed a letter of intent to provide an exclusive license…

Asia-PacificBiotechnologyDiabetesFosun PharmaLicensingPharmaceuticalSGLT2Sirona BiochemWanbang Pharma

Bayer gets Japanese OK for GI stromal tumors drug

20-08-2013

German drug major Bayer (BAYN: DE) has received approval from the Ministry of Health, Labor and Welfare…

Asia-PacificBayerBiotechnologyOncologyPharmaceuticalRegulationStivarga

First in class novel biologic for psoriasis launched in India

13-08-2013

Bangalore, India-based Biocon (BSE: 532523), Asia's premier biotechnology company, has launched its 'first…

ALZUMAbAsia-PacificBioconBiotechnologyDermatologicalsitolizumabMarkets & Marketing

Dainippon Sumitomo establishes regenerative and cellular medicine office

12-08-2013

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says that it has set up the Regenerative &…

Asia-PacificBiotechnologyDainippon Sumitomo PharmaPharmaceuticalProductionResearch

New Zealand to widen access for type 1 and type 3 Gaucher disease drug

07-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of a proposal to widen…

Asia-PacificBiotechnologyCerezymeGenzymePharmaceuticalRare diseasesRegulationSanofi

Thermo Fisher Scientific opens its first dry powder media facility in APAC region

05-08-2013

USA-based science service company Thermo Fisher Scientific (NYSE: TMO) revealed that it is expanding…

Asia-PacificBiotechnologyProductionThermo Fisher Scientific

Lonza and BioWa sign research agreement with Pfizer

30-07-2013

Swiss chemicals and drug company Lonza (SIX: LONN) and USA-based BioWa, a wholly-owned subsidiary of…

Asia-PacificBiotechnologyLonzaPfizerResearch

Bristol-Myers partners with South Korean firm on biopharma production

29-07-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

New Zealand consults on Victrelis listing and some Pegasys amendments

19-07-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to list boceprevir…

Anti-viralsAsia-PacificBiotechnologyMerck & CoPegasysPharmaceuticalRegulationRocheVictrelis

GlaxoSmithKline and Theravance withdraw Japan NDA for Relvar Ellipta in COPD

12-07-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) revealed on Friday…

Asia-PacificBiotechnologyGlaxoSmithKlinePharmaceuticalRegulationRelvar ElliptaRespiratory and PulmonaryTheravance

Soligenix collaborates with SciClone in China for SGX942 as oral mucositis therapy

09-07-2013

US clinical-stage biopharma firm Soligenix (OTCQB: SNGX) has entered into a personalized medicine collaboration…

Asia-PacificBiotechnologyLicensingOncologyResearchSciClone PharmaSGX942Soligenix

Pharming and SIPI collaboration includes Ruconest marketing in China

02-07-2013

Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

Additional indications in Japan for Roche's Avastin and Astellas' Prograf

17-06-2013

Swiss drug major Roche (ROG: SIX) says that the Japanese Ministry of Health, Labor and Welfare (MHLW)…

Asia-PacificAstellas PharmaAvastinBiotechnologyImmunologicalsOncologyPharmaceuticalPrografRegulationRoche

Bristol-Myers and Simcere agree to co-develop/commercialize Orencia SC in China

14-06-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) and China-based Simcere Pharmaceutical (NYSE: SCR) have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyBristol-Myers SquibbLicensingOrenciaPharmaceuticalSimcere Pharmaceutical

26 to 50 of 174 results

Back to top